This inventor holds 1 USPTO granted patent. Top assignees: Canon Medical Systems Corporation, Nagasaki University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,350 
1 out of 60 
Years Active: 2022
Title: Haruka Abe: Innovator in SARS-CoV-2 Detection
Introduction
Haruka Abe is a notable inventor based in Nagasaki, Japan. She has made significant contributions to the field of medical diagnostics, particularly in the detection of SARS-CoV-2. Her innovative work has implications for public health and disease management.
Latest Patents
Haruka Abe holds a patent for a primer set designed for detecting SARS-CoV-2. This patent includes a method for testing the virus, along with a reagent and kit for testing SARS-CoV-2. The primer set comprises a plurality of LAMP primers that target specific open reading frame (ORF) regions in the SARS-CoV-2 genome. The targeted ORF regions include Orf1b, OrfM, OrfN, and OrfS. This invention represents a significant advancement in the rapid and accurate detection of the virus.
Career Highlights
Throughout her career, Haruka Abe has worked with esteemed institutions such as Nagasaki University and Canon Medical Systems Corporation. Her experience in these organizations has allowed her to develop her expertise in medical technology and diagnostics.
Collaborations
Haruka has collaborated with notable colleagues, including Jiro Yasuda and Rokusuke Yoshikawa. These partnerships have contributed to her innovative research and development efforts.
Conclusion
Haruka Abe's contributions to the field of SARS-CoV-2 detection highlight her role as a leading inventor in medical diagnostics. Her work not only advances scientific knowledge but also plays a crucial role in public health initiatives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile